Linical Co Ltd (2183)

Tokyo
Currency in JPY
338.0
0.0(0.00%)
Closed
2183 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
Fair Value
Day's Range
333.0341.0
52 wk Range
323.0463.0
Key Statistics
Edit
Bid/Ask
338.00 / 341.00
Prev. Close
338
Open
338
Day's Range
333-341
52 wk Range
323-463
Volume
38.5K
Average Vol. (3m)
43.23K
1-Year Change
-16.75%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2183 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
No news in this category
Looks like there are no results in this news category

Linical Co Ltd Company Profile

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

Employees
662
Market
Japan

Compare 2183 to Peers and Sector

Metrics to compare
2183
Peers
Sector
Relationship
P/E Ratio
−32.8x11.2x−0.5x
PEG Ratio
0.24−1.270.00
Price / Book
1.0x2.2x2.6x
Price / LTM Sales
0.7x3.8x3.0x
Upside (Analyst Target)
47.9%14.8%54.9%
Fair Value Upside
Unlock24.6%9.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -10.29%
Dividend Yield
4.73%
Industry Median 0.45%
Annualized Payout
16.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 14, 2025
EPS / Forecast
-1.61 / --
Revenue / Forecast
2.53B / 3.26B
EPS Revisions
Last 90 days

FAQ

What Is the Linical Co Ltd (2183) Stock Price Today?

The Linical Co Ltd stock price today is 338.00

What Stock Exchange Does Linical Co Ltd Trade On?

Linical Co Ltd is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Linical Co Ltd?

The stock symbol for Linical Co Ltd is "2183."

Does Linical Co Ltd Pay Dividends? What’s The Current Dividend Yield?

The Linical Co Ltd dividend yield is 4.73%.

What Is the Linical Co Ltd Market Cap?

As of today, Linical Co Ltd market cap is 7.63B.

What is Linical Co Ltd Earnings Per Share?

The Linical Co Ltd EPS is -10.29.

What Is the Next Linical Co Ltd Earnings Date?

Linical Co Ltd will release its next earnings report on May 14, 2025.

From a Technical Analysis Perspective, Is 2183 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.